Study Evaluating The Mass Balance And Metabolic Disposition Of SKI-606

Wyeth

Status and phase: Completed; Phase 1

Conditions: Healthy Subjects

Treatments: Drug: SKI-606

Study type: Interventional

Funder types: Industry

Identifiers

NCT00757341

3160A4-1112-US

Details and patient eligibility

About

This study will assess the mass balance, metabolic disposition, and identification of metabolites following single oral administration of [14C]-SKI-606 in healthy male subjects.

Enrollment: 6 estimated patients

Sex: Male

Ages: 18 to 50 years old

Volunteers: Accepts Healthy Volunteers

Inclusion and exclusion criteria

Healthy men, aged 18 to 50 years.

Trial design

Primary purpose: Treatment

Allocation: Non-Randomized

Interventional model: Single Group Assignment

Masking: None (Open label)

---

6 participants in 1 patient group

SKI-606

Experimental group

Treatment:

Drug: SKI-606